COMMUNIQUÉS West-GlobeNewswire
-
PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors
16/12/2025 -
SRx Health Enters into Definitive Agreement to Acquire EMJX to Establish Next-Generation Digital Asset Treasury Operating System and Platform Led by Eric M. Jackson
16/12/2025 -
Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer
16/12/2025 -
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100
16/12/2025 -
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
16/12/2025 -
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
16/12/2025 -
J-Star Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
16/12/2025 -
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
16/12/2025 -
Sienna Completes Acquisition in Waterloo, Ontario
16/12/2025 -
Weight Watchers lance une plateforme entièrement intégrée pour une nouvelle ère de santé liée au poids
16/12/2025 -
Halo Pharma Enhances Manufacturing Capabilities with Macro-Pactor® Investment
16/12/2025 -
WEIGHT WATCHERS LANCE UNE PLATEFORME COMPLÈTE POUR LES TRAITEMENTS GLP-1
16/12/2025 -
Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program
16/12/2025 -
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
16/12/2025 -
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
16/12/2025 -
Weight Watchers lance une plateforme complète pour les traitements GLP-1
16/12/2025 -
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
16/12/2025 -
Can-Fite Provides Update on Clinical and Financial Status
16/12/2025 -
Akari Therapeutics Announces $5 Million Financing, Including Concurrent Registered Direct Offering and Private Placement Priced At-Market
16/12/2025
Pages